Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,510 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00978991 | Duke Urology Database and Specimen Bank | completed | — | 87,820 | Duke UniversityOTHER | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00004122 |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer |
| completed |
| Phase 2 |
| — |
| Roswell Park Cancer InstituteOTHER |
| 1 |
| Feb 1, 2013 |
| clinicaltrials |
| NCT00003759 | AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer | completed | Phase 2 | — | Anthra PharmaceuticalsINDUSTRY | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00055835 | S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium | completed | Phase 2 | 7 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00021099 | Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer | completed | Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00003167 | Gene Therapy in Treating Patients With Advanced Bladder Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00005831 | Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT01276665 | Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Perioperative Outcome in Patients Undergoing Radical Cystectomy | completed | N/A | 190 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01734798 | Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer | completed | Phase 3 | 198 | Cairo UniversityOTHER | 1 | Nov 28, 2012 | clinicaltrials |
| NCT00066612 | S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy | completed | Phase 2 | 45 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 2, 2012 | clinicaltrials |
| NCT00322699 | Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 22 | North Florida/South Georgia Veterans Health SystemOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00080795 | Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium | completed | Phase 2 | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00014144 | S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract | completed | Phase 2 | 31 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00006026 | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract | completed | Phase 2 | 21 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00006351 | SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract | completed | Phase 2 | 34 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00023842 | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer | completed | Phase 2 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00694798 | Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder(STCC) | completed | Phase 1 | 22 | Cadila PharnmaceuticalsINDUSTRY | 1 | May 3, 2012 | clinicaltrials |
| NCT01373398 | Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) | completed | Phase 1 | 11 | Handok Inc.INDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00744744 | Health-Related Quality of Life in Patients With Bladder Cancer | completed | — | 138 | David LatiniOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00772018 | Quality of Life and Symptom Management in Patients With Bladder Cancer | completed | — | 28 | David LatiniOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01426126 | Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum | completed | Phase 2 | 37 | Asan Medical CenterOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00971256 | Urine Cytology and Utility in Bladder Recurrence | completed | — | 10 | Corewell Health EastOTHER | 0 | Nov 23, 2011 | clinicaltrials |
| NCT00622973 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | completed | Phase 3 | 130 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01149174 | Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer(EMDA/PRE-TUR) | completed | Phase 3 | 352 | University of Rome Tor VergataOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer(BCG/EMDA-MMC) | completed | Phase 3 | 212 | University of Rome Tor VergataOTHER | 1 | Sep 28, 2011 | clinicaltrials |
| NCT00792025 | Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer | completed | Phase 2 | 80 | Institut CurieOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00186277 | Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer | completed | Phase 2 | 10 | Stanford UniversityOTHER | 1 | Mar 30, 2011 | clinicaltrials |
| NCT00859768 | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | completed | N/A | 568 | Netherlands Open UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00330707 | Combined Use of BCG and Interferon Alpha in Bladder Cancer | completed | Phase 2 / Phase 3 | 140 | National University Hospital, SingaporeOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00661609 | A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 5 | Jan 12, 2011 | clinicaltrials |
| NCT01264744 | Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test) | completed | — | 174 | Applied Spectral Imaging Ltd.INDUSTRY | 1 | Dec 23, 2010 | clinicaltrials |
| NCT00635336 | Novel Peptide Vaccination for Patients With Advanced Bladder Cancer | completed | Phase 1 | 20 | Iwate Medical UniversityOTHER | 1 | Oct 21, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00782587 | Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer(IPOP) | completed | Phase 1 | 14 | Halozyme TherapeuticsINDUSTRY | 1 | Feb 8, 2010 | clinicaltrials |
| NCT00891748 | Safety Study on AdCD40L Gene Therapy for Bladder Cancer | completed | Phase 1 / Phase 2 | 12 | Uppsala UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00315237 | Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract | completed | Phase 3 | 364 | Pierre Fabre MedicamentINDUSTRY | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00246974 | Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT | completed | Phase 2 | 125 | AstraZenecaINDUSTRY | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00696579 | Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 64 | University Of PerugiaOTHER | 1 | Jun 12, 2008 | clinicaltrials |
| NCT00315653 | Survivin Urine mRNA Assay Risk of Bladder Cancer Study | completed | — | 600 | Fujirebio Diagnostics, Inc.INDUSTRY | 1 | Mar 14, 2008 | clinicaltrials |
| NCT00490880 | Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer | completed | Phase 2 | 2 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00192049 | A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 1 | May 17, 2007 | clinicaltrials |
| NCT00191711 | Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk. | completed | Phase 2 | 43 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00011518 | Bladder Cancer Case Control Study of Arsenic in Water | completed | — | 600 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Mar 23, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Feb 8, 2013source: clinicaltrials